These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2884285)

  • 1. Particulate contaminants of intravenous medications and infusions.
    Backhouse CM; Ball PR; Booth S; Kelshaw MA; Potter SR; McCollum CN
    J Pharm Pharmacol; 1987 Apr; 39(4):241-5. PubMed ID: 2884285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative determination of particulate contamination in intravenous administration sets.
    Di Paolo ER; Hirschi B; Pannatier A
    Pharm Weekbl Sci; 1990 Oct; 12(5):190-5. PubMed ID: 2255588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Particulate and microbial contamination in in-use admixed intravenous infusions.
    Yorioka K; Oie S; Oomaki M; Imamura A; Kamiya A
    Biol Pharm Bull; 2006 Nov; 29(11):2321-3. PubMed ID: 17077539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Particulate contamination in selected parenteral drugs.
    Longe RL
    Can Anaesth Soc J; 1980 Jan; 27(1):62-4. PubMed ID: 7353193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of in-Line Filters to Completely Remove Particulate Contamination During a Pediatric Multidrug Infusion Protocol.
    Perez M; Décaudin B; Abou Chahla W; Nelken B; Storme L; Masse M; Barthélémy C; Lebuffe G; Odou P
    Sci Rep; 2018 May; 8(1):7714. PubMed ID: 29769547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Particles in small volume injections.
    Taylor SA; Spence J
    J Pharm Pharmacol; 1983 Dec; 35(12):769-73. PubMed ID: 6141237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Particulate matter test in small volume parenterals: critical aspects in sampling methodology.
    Pavanetto F; Conti B; Genta I; Ponci R; Montanari L; Grassi M
    Farmaco; 1989 Jun; 44(6):633-43. PubMed ID: 2803449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final in-line filtration: removal of contaminants from IV fluids and drugs.
    Rapp RP; Bivins BA
    Hosp Formul; 1983 Dec; 18(12):1124-8. PubMed ID: 10264358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Particle size measurement in intravenous fluids.
    Haines-Nutt RF; Munton TJ
    J Pharm Pharmacol; 1984 Aug; 36(8):534-6. PubMed ID: 6148396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of official instrumental methods for the determination of particulate matter contamination in large volume parenteral solutions.
    Montanari L; Pavanetto F; Conti B; Ponci R; Grassi M
    J Pharm Pharmacol; 1986 Nov; 38(11):785-90. PubMed ID: 2879006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Filtering effectiveness of conventional 15 m micron filters (DIN 58362) and newly developed 15 m micron and 5 m micron filters. I: Particle count].
    Walpot H; Franke RP; Burchard WG; Agternkamp C; Müller FG; Mittermayer C; Kalff G
    Infusionstherapie; 1989 Apr; 16(2):77-80. PubMed ID: 2737765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of particulate contamination in ampoules using a light blockage particle analyser.
    Alexander DM; Veltman AM
    J Pharm Pharmacol; 1985 Jan; 37(1):13-6. PubMed ID: 2858521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Particulate contamination of sterile syringes and needles.
    Taylor SA
    J Pharm Pharmacol; 1982 Aug; 34(8):493-5. PubMed ID: 6126558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of acceptance criteria for particulate limits for small-volume parenteral products.
    Tsuji K; Lewis AR
    J Pharm Sci; 1978 Jan; 67(1):50-5. PubMed ID: 619115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro analysis of overall particulate contamination exposure during multidrug IV therapy: impact of infusion sets.
    Perez M; Décaudin B; Abou Chahla W; Nelken B; Barthélémy C; Lebuffe G; Odou P
    Pediatr Blood Cancer; 2015 Jun; 62(6):1042-7. PubMed ID: 25755136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic Image Analysis To Evaluate Subvisible Particles During Continuous Drug Infusion In a Neonatal Intensive Care Unit.
    Perez M; Décaudin B; Maiguy-Foinard A; Barthélémy C; Lebuffe G; Storme L; Odou P
    Sci Rep; 2017 Aug; 7(1):9404. PubMed ID: 28839243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of the tyndall effect for enhanced visual detection of particles in compatibility testing of intravenous fluids: validity and reliability.
    Staven V; Waaseth M; Wang S; Grønlie I; Tho I
    PDA J Pharm Sci Technol; 2015; 69(2):270-83. PubMed ID: 25868993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examination of Particulate Contamination in Parenteral Injections and Infusions Following Fluid Withdrawal Utilizing Conventional Needles and Filter Needles: Assessment of Compliance and Comparative Analysis.
    van den Berg RB; Ganesh M; Crul M; Wilms EB; Swart EL; Westerman EM
    J Pharm Sci; 2024 Sep; 113(9):2668-2674. PubMed ID: 38852673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Particulate matter in I.V. infusion fluids.
    Davis NN; Turco S; Sivelly E
    Bull Parenter Drug Assoc; 1970; 24(6):257-70. PubMed ID: 5495399
    [No Abstract]   [Full Text] [Related]  

  • 20. Particulate contamination in parenteral nutrition solutions: still a cause for concern?
    Ball PA; Bethune K; Fox J; Ledger R; Barnett M
    Nutrition; 2001; 17(11-12):926-9. PubMed ID: 11744342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.